What did @jerrygetsfit actually say?
Jerry shared a personal account of using BPC-157 to manage a "nagging shoulder pain" that physical therapy and over-the-counter pain meds failed to fix. He described BPC-157 as "a peptide that comes from our stomach" that "has been shown to help with tendon and ligament healing" and claimed his shoulder pain "decreased significantly" after starting it. He also advised viewers to consult a doctor before trying it, which is worth noting.
The core claims are: BPC-157 is stomach-derived, it has demonstrated tendon and ligament healing effects, it reduces inflammation, and it meaningfully accelerated his personal recovery. Those are testable claims, and they deserve a closer look than a TikTok comment section usually provides.
Does the science back this up?
Partially, but with a very large asterisk. The animal data is genuinely interesting. The human data is essentially nonexistent.
BPC-157 is a synthetic pentadecapeptide derived from a protein found in gastric juice, so Jerry's "comes from our stomach" description is directionally correct, if simplified. Rodent studies have shown real effects on tendon-to-bone healing and angiogenesis. Sikiric et al. (2018, Current Pharmaceutical Design) documented accelerated tendon healing in rats. Chang et al. (2011, Journal of Applied Physiology) showed improved Achilles tendon recovery in a rat model. These aren't nothing.
But here's the problem: we have no randomized controlled trials in humans. Zero peer-reviewed clinical trials confirm these effects translate to people. The gap between rat tendons and a human shoulder is not a small one. Inflammation pathways differ, dosing is unstudied in humans, and bioavailability via subcutaneous injection in people hasn't been rigorously characterized in published trials.
What did they get wrong (or right)?
Jerry got the origin story roughly right. BPC-157 is derived from a gastric protein sequence, and the preclinical evidence for tendon and ligament effects is real, not invented. Giving him credit for that matters.
What he got wrong, or at least severely undersold, is the evidentiary gap. Saying it "has been shown to help with tendon and ligament healing" implies clinical proof. It does not exist yet. What exists is animal model data, which is promising but not equivalent to human evidence. Presenting personal anecdote plus rat studies as validation for a shoulder treatment is a meaningful stretch.
He also implied a relatively clean safety profile by calling it "natural." BPC-157 is a synthetic compound. It is not FDA-approved. It is not legal to sell as a dietary supplement in the US. The FDA has taken enforcement action against companies marketing it for human use. That context is absent from his video entirely.
- Correct: gastric origin of the peptide sequence
- Correct: preclinical tendon healing evidence exists
- Misleading: framing animal studies as proven human benefits
- Missing: regulatory status and safety profile in humans
What should you actually know?
BPC-157 sits in a genuinely complicated regulatory and scientific space. The preclinical data is compelling enough that serious researchers are interested. It is not snake oil. But it is also not a proven treatment for shoulder injuries in humans, full stop.
In the US, BPC-157 is not approved by the FDA for any indication. Compounding pharmacies have historically prepared it, but the FDA has moved to restrict this. Obtaining it from unverulated sources carries real risks including contamination, inaccurate dosing, and unknown long-term effects.
If you have a shoulder injury that hasn't responded to physical therapy, the evidence-based next steps involve orthopedic evaluation, possibly imaging, and potentially platelet-rich plasma therapy, which at least has some human trial data behind it (Le et al., 2014, American Journal of Sports Medicine). BPC-157 might eventually join that list. Right now, it isn't there yet.
Jerry's advice to "always consult with a doctor" before trying it is genuinely good. The problem is that most physicians won't be familiar with the compound, and sourcing it safely is its own unresolved challenge. That's the honest picture.